Schneider, Ruth

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 5.

Journal Article

Salmen, Anke; Hoepner, Robert; Fleischer, Vinzenz; Heldt, Milena; Gisevius, Barbara; Motte, Jeremias; Ruprecht, Klemens; Schneider, Ruth; Fisse, Anna Lena; Grüter, Thomas; Lukas, Carsten; Berthele, Achim; Giglhuber, Katrin; Flaskamp, Martina; Mühlau, Mark; Kirschke, Jan; Bittner, Stefan; Groppa, Sergiu; Lüssi, Felix; Bayas, Antonios; ... (2023). Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort. Therapeutic advances in neurological disorders, 16, p. 17562864231197309. Sage 10.1177/17562864231197309

Hagström, Inga T; Schneider, Ruth; Bellenberg, Barbara; Salmen, Anke; Weiler, Florian; Köster, Odo; Gold, Ralf; Lukas, Carsten (2017). Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study. Journal of neurology, 264(7), pp. 1402-1412. Springer-Medizin-Verlag 10.1007/s00415-017-8537-5

Schneider, Ruth; Bellenberg, Barbara; Hoepner, Robert; Kolb, Eva-Maria; Ellrichmann, Gisa; Haghikia, Aiden; Gold, Ralf; Lukas, Carsten (2017). Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML). PLoS ONE, 12(4), e0176415. Public Library of Science 10.1371/journal.pone.0176415

Schneider, Ruth; Bellenberg, Barbara; Hoepner, Robert; Ellrichmann, Gisa; Gold, Ralf; Lukas, Carsten (2017). Insight into Metabolic 1H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions. Frontiers in neurology, 8(454), p. 454. Frontiers Media S.A. 10.3389/fneur.2017.00454

Hoepner, Robert; Kolb, Eva M; Dahlhaus, Stefanie; Hellwig, Kerstin; Adams, Ortwin; Kleiter, Ingo; Salmen, Anke; Schneider, Ruth; Lukas, Carsten; Chan, Andrew; Berger, Joseph R; Gold, Ralf (2016). Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy. Multiple sclerosis journal, 23(6), pp. 830-835. Sage 10.1177/1352458516667241

This list was generated on Thu Nov 21 16:50:57 2024 CET.
Provide Feedback